Ann: 1H FY22 Results - Webcast Recording, page-223

When they get a product that’s not BTM to market, they’ll likely need to sell it with salespeople, even if it is easier to sell. So when BTM starts making a fair bit more money, they’ll probably use that to pay pay for more sales staff for the next product, which is due to file to FDA 2024, which has to be reviewed and approved, so probably 2025 sales start if they don’t delay again, sales staff have to be trained with the new product, it’ll take a few years to get the new product going with strong sales. Maybe 2028 might be a stellar year where they have a few product with strong sales and start laying off sales staff and minting money, but it’s ages away and I’ve perhaps underestimated the time it will all take when I invested during covid lows and after. Obviously I’m not going to sell in the red but I’m not bullish for a few years yet. All my opinion not fin. Advice